GS0351: Business services, namely, determination of patient eligibility for selection, participation and/or inclusion in clinical trials based upon specific inclusion and exclusion criteria for pharmaceutical companies, academic institutions, private companies and/or individuals that are using novel molecules to determine efficacy, effectiveness and/or safety
PM0001: DIGITAL PATIENT IDENTIFICATION AND SELECTION
Case File Event Statements
1/6/2020 - 4 years ago
20 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDType:MAB2
1/6/2020 - 4 years ago
19 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2
6/15/2019 - 5 years ago
18 - NOTIFICATION OF FINAL REFUSAL EMAILEDType:GNFN
6/15/2019 - 5 years ago
17 - FINAL REFUSAL E-MAILEDType:GNFR
6/15/2019 - 5 years ago
16 - FINAL REFUSAL WRITTENType:CNFR
5/30/2019 - 5 years ago
15 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
5/30/2019 - 5 years ago
14 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
5/30/2019 - 5 years ago
13 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
11/30/2018 - 6 years ago
12 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
11/30/2018 - 6 years ago
11 - NON-FINAL ACTION E-MAILEDType:GNRT
11/30/2018 - 6 years ago
10 - NON-FINAL ACTION WRITTENType:CNRT
11/13/2018 - 6 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
11/13/2018 - 6 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
11/13/2018 - 6 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
5/14/2018 - 6 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
5/14/2018 - 6 years ago
5 - NON-FINAL ACTION E-MAILEDType:GNRT
5/14/2018 - 6 years ago
4 - NON-FINAL ACTION WRITTENType:CNRT
5/8/2018 - 6 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
2/6/2018 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS